February 14, 2026 (Global) – and have expanded their long‑standing strategic collaboration to accelerate advanced imaging innovation for cancer care, neurodegenerative diseases, and complex interventions worldwide. The expanded partnership aims to integrate state‑of‑the‑art imaging technologies, AI‑enhanced diagnostics, and innovative clinical pathways to improve patient outcomes and support next‑generation precision care.
“Our goal is to make care more precise, less invasive and more responsive to each patient’s needs,” said Eric Williamson, M.D., Professor and Chair of Diagnostic Radiology at Mayo Clinic. “By expanding our collaboration, we can bring advanced imaging, artificial intelligence and innovative treatment approaches directly into everyday clinical care, helping patients receive earlier diagnoses and more personalised treatment plans.”
The expanded collaboration builds on both organisations’ strengths in imaging innovation, artificial intelligence and clinical research. The initiative includes multiple clinical and research priorities designed to transform cancer care and other complex disease management pathways, such as:
- AI‑enabled MRI protocols for improved diagnostics and monitoring – focusing on neurodegenerative disease and precise imaging of tumour progression by leveraging machine learning models for higher diagnostic accuracy.
- Digital twin and surgical care pathway innovation – applying simulation‑based digital modelling to enhance surgical planning and patient experience, improving care quality and operational efficiency.
- Prostate cancer diagnostics and treatment workflows – exploring ways to integrate advanced, minimally invasive imaging and AI to reduce the need for biopsies while increasing diagnostic precision.
- Image‑guided interventional suites for metastatic liver care – developing collaborative approaches to combine high‑resolution imaging and interventional tools to detect and treat metastases with enhanced precision.
- Ultra‑high‑field MRI and whole‑body PET/MR research initiatives – harnessing cutting‑edge imaging modalities for better contrast, resolution, and combined anatomical/metabolic insights to support personalised cancer care strategies.
According to Siemens Healthineers leadership, the strengthened collaboration underscores a shared commitment to enhancing diagnostic confidence and clinical precision through cutting‑edge tools that support earlier detection and more effective cancer treatment pathways. By joining clinical expertise with technological innovation, the partnership aims to improve outcomes for patients facing cancer and complex neurological diseases globally.
Industry analysts note that this type of collaboration reflects a broader trend toward integrated AI‑enabled imaging solutions that can streamline care delivery, reduce invasive procedures, and help healthcare systems adopt personalised medicine approaches more rapidly. The expansion is expected to lead to accelerated development and clinical adoption of next‑generation imaging workflows that can transform how complex diseases are detected and treated worldwide.
